Andrea Morris

Statistics

Publications

Citations

472

H-Index

Active since

1951

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

University of Michigan

Temple University

University College London

Andrea Morris is an author at GlaxoSmithKline (United States) specializing in medicine, obstructive lung disease, and chronic obstructive pulmonary disease.

Publications per year

1951–2020

Publications

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Courtney Crim, Gerard J. Criner et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 251 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD

Nicola A. Hanania, Glenn Crater, Andrea Morris et al. · Respiratory Medicine · 2011 · 83 citations

Pharmacy, Internal Medicine, Pharmacotherapy +11

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial

Bartolomé R. Celli, Julie A. Anderson, Robert D. Brook et al. · BMJ Open Respiratory Research · 2019 · 57 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

Jill Ohar, Glenn Crater, Amanda Emmett et al. · Respiratory Research · 2014 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Chronic portal vein occlusion and portal hypertension in the dog.

Andrea Morris, Hamish Miller · PubMed · 1951 · 21 citations

Medicine, Internal Medicine, Veterinary Internal Medicine +14

1–5 of 6